Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets

International Journal of Molecular Medicine

Volumn 36, Issue 1, 2015, Pages 173-185

  Huang, Chenghu ^a   Yuan, Li ^a   Cao, Shuyi ^a  

^a UNION HOSPITAL   (China)

Author keywords

Glucagon like peptide 1; Inflammation; Lipotoxicity; Oxidative stress; Pancreatic islet; Prohormone convertase 1 3

Indexed keywords

ACETYLCYSTEINE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIRAGLUTIDE; PALMITIC ACID; PROHORMONE CONVERTASE 1; PROPROTEIN CONVERTASE 1; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; EXENDIN (9-39); HOMEODOMAIN PROTEIN; PALMITIC ACID DERIVATIVE; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; PEPTIDE FRAGMENT; RELA PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE EXPRESSION; INFLAMMATION; INHIBITION KINETICS; LIPOTOXICITY; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; LIPID DIET; METABOLISM; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOLOGY; PHYSIOLOGY;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DIET, HIGH-FAT; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLUCAGON-SECRETING CELLS; HOMEODOMAIN PROTEINS; INFLAMMATION; INSULIN-SECRETING CELLS; LIRAGLUTIDE; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PALMITATES; PEPTIDE FRAGMENTS; PROPROTEIN CONVERTASE 1; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA;

EID: 84930330603     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2207     Document Type: Article

References (43)

1. Kusminski CM, Shetty S, Orci L, Unger RH and Scherer PE: Diabetes and apoptosis: Lipotoxicity. Apoptosis 14: 1484-1495, 2009.
2. Kim JW and Yoon KH: Glucolipotoxicity in pancreatic β-cells. Diabetes Metab J 35: 444-450, 2011.
3. Rial E, Rodríguez-Sánchez L, Gallardo-Vara E, Zaragoza P, Moyano E and González-Barroso MM: Lipotoxicity, fatty acid uncoupling and mitochondrial carrier function. Biochim Biophys Acta 1797: 800-806, 2010.
4. Kim W and Egan JM: The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 60: 470-512, 2008.
5. Buteau J: GLP-1 receptor signaling: Effects on pancreatic beta-cell proliferation and survival. Diabetes Metab 34 (Suppl 2): S73-S77, 2008.
6. Lamont BJ and Andrikopoulos S: Hope and fear for new classes of type 2 diabetes drugs: Is there preclinical evidence that incretin-based therapies alter pancreatic morphology? J Endocrinol 221: T43-T61, 2014.
7. Yang Y, Tong Y, Gong M, Lu Y, Wang C, Zhou M, Yang Q, Mao T and Tong N: Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor. Cell Signal 26: 268-278, 2014.
8. Kemp DM and Habener JF: Insulinotropic hormone glucagon-like peptide-1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase. Endocrinology 142: 1179-1187, 2001.
9. Lotfy M, Singh J, Rashed H, Tariq S, Zilahi E and Adeghate E: Mechanism of the beneficial and protective effects of exenatide in diabetic rats. J Endocrinol 220: 291-304, 2014.
10. Chen LN, Lyu J, Yang XF, Ji WJ, Yuan BX, Chen MX, Ma X and Wang B: Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice. Int J Mol Med 32: 892-900, 2013.
11. Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R, Yokomizo H, Hirata E, Sonoda N and Takayanagi R: GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism 61: 1422-1434, 2012.
12. Liu Z, Stanojevic V, Avadhani S, Yano T and Habener JF: Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia 54: 2067-2076, 2011.
13. Pugazhenthi U, Velmurugan K, Tran A, Mahaffey G and Pugazhenthi S: Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: Potential therapeutic benefits in diabetic patients. Diabetologia 53: 2357-2368, 2010.
14. Marchetti P, Lupi R, Bugliani M, Kirkpatrick CL, Sebastiani G, Grieco FA, Del Guerra S, D'Aleo V, Piro S, Marselli L, et al: A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 55: 3262-3272, 2012.
15. Habener JF and Stanojevic V: Alpha cells come of age. Trends Endocrinol Metab 24: 153-163, 2013.
16. Habener JF and Stanojevic V: α-cell role in β-cell generation and regeneration. Islets 4: 188-198, 2012.
17. Nie Y, Nakashima M, Brubaker PL, Li QL, Perfetti R, Jansen E, Zambre Y, Pipeleers D and Friedman TC: Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest 105: 955-965, 2000.
18. Zhang Y, Zhang Y, Bone RN, Cui W, Peng JB, Siegal GP, Wang H and Wu H: Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. PLoS One 7: e36675, 2012.
19. Yano T, Liu Z, Donovan J, Thomas MK and Habener JF: Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes 56: 2946-2957, 2007.
20. Thyssen S, Arany E and Hill DJ: Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 147: 2346-2356, 2006.
21. Lau T, Carlsson PO and Leung PS: Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47: 240-248, 2004.
22. Wang HW, Mizuta M, Saitoh Y, Noma K, Ueno H and Nakazato M: Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells. Metabolism 60: 1081-1089, 2011.
23. Jaksch C and Thams P: A critical role for CK2 in cytokine-induced activation of NFκB in pancreatic β cell death. Endocrine 47: 117-128, 2014.
24. Yuan L, Lu CL, Wang Y, Li Y and Li XY: Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways. J Diabetes Res 2014: 391476, 2014.
25. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB and Mandarim-de-Lacerda CA: A mouse model of metabolic syndrome: Insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46: 212-223, 2010.
26. Davidson HW: (Pro)Insulin processing: A historical perspective. Cell Biochem Biophys 40 (Suppl 3): 143-158, 2004.
27. Portela-Gomes GM, Grimelius L and Stridsberg M: Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreas. Regul Pept 146: 117-124, 2008.
28. Kieffer TJ, McIntosh CH and Pederson RA: Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596, 1995.
29. Mondragon A, Davidsson D, Kyriakoudi S, Bertling A, Gomes-Faria R, Cohen P, Rothery S, Chabosseau P, Rutter GA and da Silva Xavier G: Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia. PLoS One 9: e104873, 2014.
30. Gloire G, Legrand-Poels S and Piette J: NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
31. Quan W, Jo EK and Lee MS: Role of pancreatic β-cell death and inflammation in diabetes. Diabetes Obes Metab 15 (Suppl 3): 141-151, 2013.
32. O'Malley TJ, Fava GE, Zhang Y, Fonseca VA and Wu H: Progressive change of intra-islet GLP-1 production during diabetes development. Diabetes Metab Res Rev 30: 661-668, 2014.
33. Hansen AM, Bödvarsdottir TB, Nordestgaard DN, Heller RS, Gotfredsen CF, Maedler K, Fels JJ, Holst JJ and Karlsen AE: Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus - an adaptive response to hyperglycaemia? Diabetologia 54: 1379-1387, 2011.
34. Talchai C, Xuan S, Lin HV, Sussel L and Accili D: Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150: 1223-1234, 2012.
35. Wang Z, York NW, Nichols CG and Remedi MS: Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab 19: 872-882, 2014.
36. Tortosa F and Dotta F: Incretin hormones and beta-cell mass expansion: What we know and what is missing? Arch Physiol Biochem 119: 161-169, 2013.
37. Evans JL, Goldfine ID, Maddux BA and Grodsky GM: Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
38. Yuzefovych LV, LeDoux SP, Wilson GL and Rachek LI: Mitochondrial DNA damage via augmented oxidative stress regulates endoplasmic reticulum stress and autophagy: Crosstalk, links and signaling. PLoS One 8: e83349, 2013.
39. Gehrmann W, Elsner M and Lenzen S: Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β-cells. Diabetes Obes Metab 12 (Suppl 2): 149-158, 2010.
40. Erdogdu O, Eriksson L, Xu H, Sjöholm A, Zhang Q and Nyström T: Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways. J Mol Endocrinol 50: 229-241, 2013.
41. Jin L, Lim SW, Doh KC, Piao SG, Jin J, Heo SB, Chung BH and Yang CW: Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. PLoS One 9: e100798, 2014.
42. Tomas E, Stanojevic V and Habener JF: GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes. Regul Pept 167: 177-184, 2011.
43. Liu Z, Stanojevic V, Brindamour LJ and Habener JF: GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity. J Endocrinol 213: 143-154, 2012.